Thermo Fisher Scientific (TMO) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 2.21 | 2.31 | 2.53 | 2.30 | 2.68 | 3.58 | |||
| Changes by years, y/y, % | -17% | +4% | +10% | -9% | +16% | +19.1% | |||
Thermo Fisher Scientific. Debt/EBITDA
Thermo Fisher Scientific. Debt/EBITDA, changes, %
Thermo Fisher Scientific (TMO) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Debt/EBITDA | 2.44 | 2.53 | 2.84 | 2.68 | 3.58 | 3.58 | ||
| Changes by years, y/y, % | -2% | +12% | +16% | +16% | +47% | |||
| Changes by quarters, q/q, % | +5% | +4% | +12% | -6% | +33% | |||